As of May 28, 2025, Ramsay Generale de Sante SA (GDS.PA) reports a ROE (Return on Equity) of -4.51%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Ramsay Generale de Sante SA's ROE (Return on Equity)
Over recent years, Ramsay Generale de Sante SA's ROE (Return on Equity) has shown significant volatility. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2024-06-30 | -4.51% |
| 2023-06-30 | 3.97% |
| 2022-06-30 | 9.69% |
| 2021-06-30 | 6.07% |
| 2020-06-30 | 1.32% |
This slight upward trend highlights how Ramsay Generale de Sante SA manages its efficiency in generating profits from shareholders' equity over time.
Comparing Ramsay Generale de Sante SA's ROE (Return on Equity) to Peers
To better understand Ramsay Generale de Sante SA's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Ramsay Generale de Sante SA (GDS.PA) | -4.51% |
| Orpea SA (ORP.PA) | 71.82% |
| Clinica Baviera SA (CBAV.MC) | 41.48% |
| Gen Digital Inc (GEN) | 28.36% |
| MATERNUS-Kliniken-AG (MAK.DE) | 26.52% |
| Swissmed Centrum Zdrowia SA (SWD.WA) | 22.47% |
Compared to its competitors, Ramsay Generale de Sante SA's ROE (Return on Equity) is lower than all peers, which may indicate less effective deployment of shareholders' capital.